However, with the continuous mutation of the influenza virus genes, especially when the active site or adjacent amino acid sites of NA and PA undergo mutations, it may reduce the binding of the inhibitor to NA and PA, and reduce the virus’s sensitivity to the inhibitor, resulting in drug-resistant mutants that make the treatment of influenza more challenging (Takashita, 2021). The gene discussed is XK; the disease is influenza.